Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Benefits of NHS partnerships with private advanced diagnostics companies

Michael Hubank • 17 Oct 2021
General

Michael Hubank, PhD, The Royal Marsden NHS Foundation Trust, London, UK, discusses partnerships between the NHS and private advanced diagnostics companies, including how to balance concerns over privatisation with getting access to the best technology and care for patients.

Disclosures

Prof. Hubank has received personal or laboratory financial support received for talks and/or advisory boards from Guardant Health, and also from Amgen, Astex Pharmaceuticals, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Lilly, Illumina, Incyte, Merck, Novartis, Qiagen, Roche Diagnostics.

More from Michael Hubank

2:29
Advantages of liquid biopsy for patients
Michael Hubank • 17 Oct 2021
8:06
State-of-the-art liquid biopsy facility at the Royal Marsden
Michael Hubank • 17 Oct 2021

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals